Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis

Marco Schito, Trevor F. Peter, Sean Cavanaugh, Amy S. Piatek, Gloria J. Young, Heather Alexander, William Coggin, Gonzalo J. Domingo, Dennis Ellenberger, Eugen Ermantraut, Ilesh V. Jani, Achilles Katamba, Kara M. Palamountain, Shaffiq Essajee, David Wesley Dowdy

Research output: Contribution to journalArticle

Abstract

Stakeholders agree that supporting high-quality diagnostics is essential if we are to continue to make strides in the fight against human immunodeficiency virus (HIV) and tuberculosis. Despite the need to strengthen existing laboratory infrastructure, which includes expanding and developing new laboratories, there are clear diagnostic needs where conventional laboratory support is insufficient. Regarding HIV, rapid point-of-care (POC) testing for initial HIV diagnosis has been successful, but several needs remain. For tuberculosis, several new diagnostic tests have recently been endorsed by the World Health Organization, but a POC test remains elusive. Human immunodeficiency virus and tuberculosis are coendemic in many high prevalence locations, making parallel diagnosis of these conditions an important consideration. Despite its clear advantages, POC testing has important limitations, and laboratory-based testing will continue to be an important component of future diagnostic networks. Ideally, a strategic deployment plan should be used to define where and how POC technologies can be most efficiently and cost effectively integrated into diagnostic algorithms and existing test networks prior to widespread scale-up. In this fashion, the global community can best harness the tremendous capacity of novel diagnostics in fighting these 2 scourges.

Original languageEnglish (US)
JournalJournal of Infectious Diseases
Volume205
Issue numberSUPPL. 2
DOIs
StatePublished - May 15 2012

Fingerprint

Point-of-Care Systems
Tuberculosis
HIV
Costs and Cost Analysis
Routine Diagnostic Tests

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. / Schito, Marco; Peter, Trevor F.; Cavanaugh, Sean; Piatek, Amy S.; Young, Gloria J.; Alexander, Heather; Coggin, William; Domingo, Gonzalo J.; Ellenberger, Dennis; Ermantraut, Eugen; Jani, Ilesh V.; Katamba, Achilles; Palamountain, Kara M.; Essajee, Shaffiq; Dowdy, David Wesley.

In: Journal of Infectious Diseases, Vol. 205, No. SUPPL. 2, 15.05.2012.

Research output: Contribution to journalArticle

Schito, M, Peter, TF, Cavanaugh, S, Piatek, AS, Young, GJ, Alexander, H, Coggin, W, Domingo, GJ, Ellenberger, D, Ermantraut, E, Jani, IV, Katamba, A, Palamountain, KM, Essajee, S & Dowdy, DW 2012, 'Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis', Journal of Infectious Diseases, vol. 205, no. SUPPL. 2. https://doi.org/10.1093/infdis/jis044
Schito, Marco ; Peter, Trevor F. ; Cavanaugh, Sean ; Piatek, Amy S. ; Young, Gloria J. ; Alexander, Heather ; Coggin, William ; Domingo, Gonzalo J. ; Ellenberger, Dennis ; Ermantraut, Eugen ; Jani, Ilesh V. ; Katamba, Achilles ; Palamountain, Kara M. ; Essajee, Shaffiq ; Dowdy, David Wesley. / Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. In: Journal of Infectious Diseases. 2012 ; Vol. 205, No. SUPPL. 2.
@article{6be284b27d9a40fd9baae1011f2f701f,
title = "Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis",
abstract = "Stakeholders agree that supporting high-quality diagnostics is essential if we are to continue to make strides in the fight against human immunodeficiency virus (HIV) and tuberculosis. Despite the need to strengthen existing laboratory infrastructure, which includes expanding and developing new laboratories, there are clear diagnostic needs where conventional laboratory support is insufficient. Regarding HIV, rapid point-of-care (POC) testing for initial HIV diagnosis has been successful, but several needs remain. For tuberculosis, several new diagnostic tests have recently been endorsed by the World Health Organization, but a POC test remains elusive. Human immunodeficiency virus and tuberculosis are coendemic in many high prevalence locations, making parallel diagnosis of these conditions an important consideration. Despite its clear advantages, POC testing has important limitations, and laboratory-based testing will continue to be an important component of future diagnostic networks. Ideally, a strategic deployment plan should be used to define where and how POC technologies can be most efficiently and cost effectively integrated into diagnostic algorithms and existing test networks prior to widespread scale-up. In this fashion, the global community can best harness the tremendous capacity of novel diagnostics in fighting these 2 scourges.",
author = "Marco Schito and Peter, {Trevor F.} and Sean Cavanaugh and Piatek, {Amy S.} and Young, {Gloria J.} and Heather Alexander and William Coggin and Domingo, {Gonzalo J.} and Dennis Ellenberger and Eugen Ermantraut and Jani, {Ilesh V.} and Achilles Katamba and Palamountain, {Kara M.} and Shaffiq Essajee and Dowdy, {David Wesley}",
year = "2012",
month = "5",
day = "15",
doi = "10.1093/infdis/jis044",
language = "English (US)",
volume = "205",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis

AU - Schito, Marco

AU - Peter, Trevor F.

AU - Cavanaugh, Sean

AU - Piatek, Amy S.

AU - Young, Gloria J.

AU - Alexander, Heather

AU - Coggin, William

AU - Domingo, Gonzalo J.

AU - Ellenberger, Dennis

AU - Ermantraut, Eugen

AU - Jani, Ilesh V.

AU - Katamba, Achilles

AU - Palamountain, Kara M.

AU - Essajee, Shaffiq

AU - Dowdy, David Wesley

PY - 2012/5/15

Y1 - 2012/5/15

N2 - Stakeholders agree that supporting high-quality diagnostics is essential if we are to continue to make strides in the fight against human immunodeficiency virus (HIV) and tuberculosis. Despite the need to strengthen existing laboratory infrastructure, which includes expanding and developing new laboratories, there are clear diagnostic needs where conventional laboratory support is insufficient. Regarding HIV, rapid point-of-care (POC) testing for initial HIV diagnosis has been successful, but several needs remain. For tuberculosis, several new diagnostic tests have recently been endorsed by the World Health Organization, but a POC test remains elusive. Human immunodeficiency virus and tuberculosis are coendemic in many high prevalence locations, making parallel diagnosis of these conditions an important consideration. Despite its clear advantages, POC testing has important limitations, and laboratory-based testing will continue to be an important component of future diagnostic networks. Ideally, a strategic deployment plan should be used to define where and how POC technologies can be most efficiently and cost effectively integrated into diagnostic algorithms and existing test networks prior to widespread scale-up. In this fashion, the global community can best harness the tremendous capacity of novel diagnostics in fighting these 2 scourges.

AB - Stakeholders agree that supporting high-quality diagnostics is essential if we are to continue to make strides in the fight against human immunodeficiency virus (HIV) and tuberculosis. Despite the need to strengthen existing laboratory infrastructure, which includes expanding and developing new laboratories, there are clear diagnostic needs where conventional laboratory support is insufficient. Regarding HIV, rapid point-of-care (POC) testing for initial HIV diagnosis has been successful, but several needs remain. For tuberculosis, several new diagnostic tests have recently been endorsed by the World Health Organization, but a POC test remains elusive. Human immunodeficiency virus and tuberculosis are coendemic in many high prevalence locations, making parallel diagnosis of these conditions an important consideration. Despite its clear advantages, POC testing has important limitations, and laboratory-based testing will continue to be an important component of future diagnostic networks. Ideally, a strategic deployment plan should be used to define where and how POC technologies can be most efficiently and cost effectively integrated into diagnostic algorithms and existing test networks prior to widespread scale-up. In this fashion, the global community can best harness the tremendous capacity of novel diagnostics in fighting these 2 scourges.

UR - http://www.scopus.com/inward/record.url?scp=84860373242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860373242&partnerID=8YFLogxK

U2 - 10.1093/infdis/jis044

DO - 10.1093/infdis/jis044

M3 - Article

C2 - 22457286

AN - SCOPUS:84860373242

VL - 205

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - SUPPL. 2

ER -